fda covid vaccine - Search News

Order byBest matchMost fresh

FDA, Covid and vaccines

FDA panel says Covid vaccines can stay the same for fall amid access concerns

Complicating matters, however, were new FDA rules for the updated Covid vaccines, announced just days earlier, that would restrict access of the shots to only the most at-risk Ame

· 7h · on MSN

· 13h

FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines

· 1d · on MSN

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

New Trump vaccine policy limits access to COVID shots

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some p...

· 1d

· 9h

FDA panel recommends keeping COVID shots targeted to same strain as last year

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 13h

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

· 14h

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

FDA, COVID-19

Digest more

FDA won’t approve COVID shot for healthy, non-elderly population

Emily Martin, a professor of epidemiology at the University of Michigan School of Public Health, said in an interview that she agrees “100 percent” that there should be more data on the age 50 to 64 ...

· 17h

· 2d · on MSN

FDA to limit covid shot approval to 65+, those with medical conditions

· 1d · on MSN

FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications

5hon MSN

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,

13h

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat

Covid Vaccine Boosters Won’t Be Available for Healthy Adults Under 65. How Will That Work?

On May 20, U.S. Food and Drug Administration ( FDA) officials announced that Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and older, and those with certain medical conditions that put them at high risk for severe infection.

Explore more

Food and Drug Administration